Fosun Pharma To Acquire India’s Gland Pharma Stake From KKR For $1.26B
July 29, 2016 — 10:54 CST
This Data Is Locked!
This area is available only to Subscribers.
Shanghai Fosun Pharmaceutical (Group) Co. has signed a definitive agreement to acquire 86% of India’s Gland Pharma, a pure-play generic injectable pharmaceutical products firm backed... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals